Viva Biotech Holdings revenue breakdown overview

Viva Biotech Holdings revenue for the last year amounted to 303.61 M USD, the most of which — 185.43 M USD — came from its highest performing source at the moment, Contract Development Manufacture Organisation and Commercialisation, the year earlier bringing 220.99 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Viva Biotech Holdings 114.99 M USD, and the year before that — 136.33 M USD.